SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis. DEA finally relents.

DEA 52

DEA Research and Development Data Cannabis 52

Veriheal

SEPTEMBER 13, 2022

Research from New Frontier Data estimates that around 3 million people grow their own cannabis at home in the United States. The research conducted by New Frontier Data went on to show that 65% of those who grow cannabis at home were in a relationship or married, and 46% had children under the age of 18. Will you be one of them?

Cultivation 111

Cultivation Data DEA Dispensary 111

Cannabis Law Report

JULY 20, 2022

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 Nevertheless, the federal law and enforcement policy remained the same. million marijuana plants and conducted more than 6,600 marijuana related arrests.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JULY 18, 2022

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 Nevertheless, the federal law and enforcement policy remained the same. million marijuana plants and conducted more than 6,600 marijuana related arrests.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JUNE 16, 2022

million cultivated marijuana plants and made more than 6,600 marijuana-related arrests in 2021, according to annual data compiled by the US Drug Enforcement Administration. . Federal law enforcement agents and their partners seized over 5.5 million cultivated cannabis plants last year – a 20 percent increase over 2020’s totals.

DEA 52

DEA Marijuana Programs Data 52

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

The Blunt Truth

MARCH 10, 2020

The latter requires extensive vetting , including analyses of the underlying target condition and other related available treatments, conducting a cost benefit analysis from clinical data, as well as strategizing on how drug risks may be identified and mitigated. CBD Class Action Litigation.

CBD 99

CBD Topical Agriculture Hemp 99

The Cannigma

MAY 16, 2025

There is a shift happening in this country, away from liberal policies, including drug policy reforms. The unstable legality of federal protections for medical cannabis, which solely come from an amendment to the DOJ and DEAs budget that has to pass every year, threatens our progress. How do we move federal policies forward?

Policy 79

Policy Access Advocacy Patients 79

Illinois News Joint

NOVEMBER 6, 2024

percent have been interpreted by the Drug Enforcement Administration (DEA) as federally legal hemp. It (HB5903) would bankrupt the licensed operators and tank the industry and its policy goals of rebuilding DIAs,” Howard said. Say that Delta-8 is safe despite never being used by humans until 2021 and no safety data exists on it.

Hemp 78

Hemp Agriculture THC DEA 78

Veriheal

DECEMBER 27, 2022

Researchers have taken a big step in understanding the connection between using psychedelics and feeling connected to nature in a study published in the journal Drug Science, Policy, and Law on Oct. The subjective nature of self-reported data can plague research.

Research and Development 102

Research and Development Therapy Consumption DEA 102

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 60

Decriminalization Policy Research and Development Data 60

Cannabis Law Report

AUGUST 23, 2021

He added that significant data is still needed to inform policy regarding use of consumer cannabis products. She acknowledged that “FDA is considering the possibility of new legal pathways for CBD products.”.

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

JUNE 1, 2021

.” 1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

AUGUST 6, 2021

1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country. hemp industry in the U.S.,

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. MAPS hired Sylvia Thyssen as our first employee , celebrated the 50th anniversary of LSD , outlined perspectives on drug policy , and worked toward facilitating a pilot study for medical marijuana. Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

SpeedWeed

APRIL 3, 2021

The federal Drug Enforcement Administration (DEA) has, in a proposed rule, indirectly classified delta-8 THC as a Schedule I controlled substance, which would make it federally illegal. Additionally, in August 2020, the DEA released an Interim Final Rule (IFR) , a document meant to update and confirm the differences between hemp and cannabis.

THC 52

THC Extraction Hemp CBD 52

Cannabis Law Report

JULY 30, 2019

Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. “Today, Americans for Safe Access (ASA), the leading advocacy organization dedicated to ensuring safe and legal access to cannabis (marijuana) for therapeutic use and research, and Aurelius Data , Inc.(AD),

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

AUGUST 16, 2019

Immediately, regulators in other states with newly legalized programs will seek to avoid similar pitfalls while striking an effective regulatory balance: Oregon’s unlimited license policy is an opposite example of what other states yet prefer to avoid. Florida’s marijuana future is showing promise.

Marijuana 49

Marijuana Research and Development Seed-To-Sale Education 49

SpeedWeed

DECEMBER 28, 2018

Which Cannabis Strains Are Highest in CBD, According to Lab Data? There’s nothing to justify the sky-high price (about $90 per day) beyond the cost of research and development to win FDA approval. RELATED STORY.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Canna Law Blog

JULY 26, 2023

I did my best to confirm Beau’s statement and was reminded of how challenging it has always been to aggregate data in this space. The study with 2017 data contains a disclaimer that “not all States reported data on the same basis.” Also, the 2017 data includes acreage for “approved” and not exclusively “cultivated”, hemp.

Hemp 98

Hemp DEA THC Policy 98

The Cannigma

JUNE 14, 2021

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We Unfortunately, this change in policy has been promised for years and never actually materialized.”.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

CannaMD

SEPTEMBER 10, 2020

Data from the National Institute of Health indicates that younger women are more likely to use marijuana during pregnancy, with urine toxicology testing showing that 19% of pregnant women aged 18-25 screened positive for marijuana use. These numbers reflect both non-medical and medicinal marijuana use.

Marijuana 88

Marijuana Therapy Data THC 88

Cannabis Law Report

JULY 23, 2021

Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). It would transfer primary agency jurisdiction over cannabis from the DEA to the FDA, TTB, and ATF. If implemented, regulatory responsibility of cannabis would be transferred from the U.S.

Research and Development 81

Research and Development DEA Programs State Laws 81

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA).

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Connor & Connor PLLC

AUGUST 15, 2024

If Congress would like to change the legal status of marijuana, they would do so before or after the DEA makes a final scheduling decision. On May 21, 2024, the DEA opened a 62-day public comment period, which concluded on July 22, 2024. Currently, rescheduling marijuana to Schedule III of the CSA is being considered.

Marijuana 52

Marijuana DEA Policy Business 52

CannaMD

SEPTEMBER 15, 2020

To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies. After this data has been entered, the information will be reviewed and you will receive your medical marijuana card. The Florida Highway Patrol Policy Manual outlines these rights.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

NOVEMBER 4, 2021

Should President Biden wish to acknowledge the political, economic, and moral realities surrounding cannabis policy, and fulfill the promises he made on the campaign trail, this report lays out a clear roadmap for how to do so.”. We’re beyond that.”. The FDA Director role continues to be unfilled. That’s all it is.

DEA 52

DEA Marijuana Decriminalization Data 52

Cannabis Law Report

MARCH 3, 2022

Clinton’s drug policy record while in office has been widely criticized by advocates. He also rejected requests to lift a federal ban on harm reduction policies like syringe exchange programs. that focused almost exclusively on the potential harms rather than benefits.

Media 52

Media CBD Events THC 52

Cannabis Law Report

NOVEMBER 2, 2021

Every lab uses a different method so the data is not going to be consistent.”. Since none of the 8 products fully tested were found to contain impurities, the information in the cannabinoid analysis pages contain the relevant data. The second argument is based on a DEA interim final rule on the topic of synthetic THC.

THC 96

THC CBD Legalization Vaping 96

SpeedWeed

AUGUST 19, 2021

And now that delta-8 THC , its trendy cousin, has been outlawed in some states across the country and flagged by the DEA , THC-O’s star may rise even faster. . THC-O didn’t appear on the DEA’s radar until nearly 30 years later. Typically, acetic anhydride is added to delta-8 THC to produce delta-O acetate. Is THC-O safe to consume?

THC 40

THC Hemp Extraction Vaping 40

Cannabis Law Report

SEPTEMBER 19, 2019

” Additionally, Marijuana Policy Project’s resources on Medical Marijuana indicate that: “ Because Congress and the DEA have failed to make medical cannabis legal — despite ample evidence of its safety and efficacy —polls consistently show that states have enacted their own laws to protect patients.”

Vaping 55

Vaping Hemp Education Patients 55

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

As policies become more data-driven and progressive, cultivation and production technologies have continued to improve drastically over the past several years. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.

Recreational 52

Recreational Data Cannabis DEA 52

Veriheal

OCTOBER 14, 2022

Air Force changed its THC testing policy, and a DEA historian talked about the organization’s racist origins. Air Force (USAF) made some huge changes to its cannabis policy. After the two-year trial period, the USAF plans to analyze the data to see if the program is effective. Let’s dive into this week’s cannanews.

Policy 112

Policy THC DEA Programs 112

Cannabis Law Report

SEPTEMBER 20, 2019

DEA increases the cannabis research quota. Data indicates cannabis-containing vaping products losing market share to other cannabis products after recently reported health concerns. Headset data reflects that the share of vaping sales have declined materially in the wake of the recently publicized vaping health concerns.

Vaping 40

Vaping Banking Research and Development DEA 40

Canna Law Blog

NOVEMBER 6, 2021

The following year, President Richard Nixon declared drug abuse public enemy number one, and in 1973, he formed the Drug Enforcement Administration (DEA). The DEA limits how much psilocybin can be produced annually, which drives up costs, and the agency imposes other unnecessary burdens on researchers. The first is legislative.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

NORML

FEBRUARY 18, 2020

Because cannabis is still illegal under federal law, the DEA and other federal law enforcement would be able to use federal funds to shut down medical marijuana programs. The data speaks for itself. Sign our petition, and make it crystal clear to our representatives that if they support this budget, we will not support them.

Marijuana 362

Marijuana DEA Programs Patients 362

Cannabis Law Report

MARCH 25, 2019

Both paths are complex processes in which scientific, medical, policy and political forces have influence. There are other avenues Congress can take besides rescheduling marijuana to ameliorate the seeming breakdown in federalism brought about by federal marijuana policy. It was not a policy priority of the Obama administration.

Banking 45

Banking Law Marijuana State Laws 45